Critical Care Pharmacy Specialty Review Course for Recertification, Core Therapeutic Modules + RECERT EXAMS Package (Cert # L219197)

ACPE Numbers: Various – see listing below
Pre-Sale Date: 09/01/2021
Content Release Date: 09/22/2021
Expiration Date: 09/20/2022
Activity Type: Application-based
CE Credits: 19.25 (BPS and ACPE) contact hours
Activity Fee: $475 (ASHP member); $675 (non-member)

Activity Overview

This course is intended for BCCCPs in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS) to provide an overview of recent standards and guidelines that specialists should be familiar with in practice. The course uses a case-based approach to discuss patient care issues. In this series, faculty will:

  • Review pertinent clinical topics and practice skills
  • List valuable resources for further self-study 

This online course consists of 14 activities (see tables below) and provides up to 19.25 contact hours of continuing pharmacy education credit and/or recertification credit.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  

These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in critical care pharmacy.

Board certified pharmacists are eligible to receive up to 19.25 contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed.  You are allowed only one attempt to successfully complete this assessment.

This course is not intended for those preparing to take the BPS Critical Care Pharmacy Specialty Examination for Certification. To prepare for the examination, please see courses here: http://elearning.ashp.org/catalog/Crit-care-review

These activities are part of the ASHP professional development program for BCCCP recertification approved by the BPS.

* Please note: Review Course for Recertification may only be completed for recertification credit up to two times, in nonconsecutive years, during the 7-year recertification cycle

The review course for recertification consists of 11 activities (see table below). In each activity, faculty review clinical topics and practice skills using a case-based approach. This package is intended for board certified pharmacists in need of recertification credit; the activities were designed based on the content outline developed by the Board of Pharmacy Specialties (BPS).

Learning Activity

ACPE Number

Contact

Hours

*Assessment Pass Point

Complex Case: Complications after Cardiac Surgery - Glucose, Sedation, and Thrombocytopenia

0204-0000-21-987-H01-P

1.50

75%

Complex Case: Acute Coronary Syndrome

0204-0000-21-988-H01-P

1.50

Complex Case: Antithrombotic-Associated Intracerebral Hemorrhage

0204-0000-21-989-H01-P

1.50

Complex Case: Sepsis

0204-0000-21-990-H01-P

1.50

Group 1 Assessment   

6.0 

Complex Case: Hyperglycemic Emergency and Community-Acquired Pneumonia

0204-0000-21-991-H01-P

1.50

76%

Complex Case: Pneumonia

0204-0000-21-992-H01-P

1.50

Complex Case: Oncologic Emergencies: Febrile Neutropenia, Tumor Lysis Syndrome, and Hypercalcemia of Malignancy

0204-0000-21-993-H01-P

1.50

Complex Case: GI Bleeding and Acute Renal Failure

0204-0000-21-994-H01-P

1.50

Group 2 Assessment   

6.0 

Statistics, Evidence-Based Medicine, and Clinical Trial Design

0204-0000-21-985-H04-P

2.00

77%

Practice Administration and Development Part 1

0204-0000-21-995-H04-P

1.00

Practice Administration and Development Part 2

0204-0000-21-996-H04-P

1.00

Group 3 Assessment   

4.0 

After participating in this CPE activity, learners should be able to:

Complex Case: Complications after Cardiac Surgery - Glucose, Sedation, and Thrombocytopenia
ACPE #: 0204-0000-21-987-H01-P

  • Develop treatment and monitoring plans for a complex post-cardiac surgery patient to include pain, agitation and delirium, glucose management, and heparin-induced thrombocytopenia.
  • Evaluate the impact of critical illness on pre-existing conditions (e.g., endocrine disorders, pain).
  • Summarize quality assurance and process improvement methods relevant to critical care.
  • Assess the relationship between institutional guideline development and evidence-based critical care literature.

Complex Case: Acute Coronary Syndrome
ACPE #: 0204-0000-21-988-H01-P

  • Develop treatment and monitoring plans for a complex critical care patient with acute coronary syndrome.
  • Modify treatment and monitoring plans related to alterations of pharmacodynamics and pharmacokinetics in the critically ill.
  • Select devices required for treatment and monitoring of a critical care patient.
  • Select fluid, electrolyte and acid/base management and monitoring based on patient-specific factors.

Complex Case: Antithrombotic-Associated Intracerebral Hemorrhage
ACPE #: 0204-0000-21-989-H01-P

  • Develop treatment and monitoring plans for a complex critical care patient with antithrombotic-associated intracerebral hemorrhage (ICH).
  • Select appropriate neurologic monitoring techniques.
  • Recommend agents for acute volume resuscitation and hemostasis (e.g., blood products, hemostatic agents).
  • Evaluate the impact of critical illness on preexisting conditions (e.g., cardiovascular diseases).
  • Recommend fluid and electrolyte management based on patient-specific factors.

Complex Case: Sepsis
ACPE #: 0204-0000-21-990-H01-P

  • Develop treatment and monitoring plans for a complex critical care patient with intra-abdominal infection, sepsis/SIRS, and shock.
  • Select appropriate routes of administration for medications in critically ill patients.
  • Modify treatment and monitoring plans related to alterations of pharmacodynamics and pharmacokinetics in the critically ill.
  • Recommend agents for acute volume resuscitation and hemostasis (e.g., crystalloids, colloids).

Complex Case: Hyperglycemic Emergency and Community-Acquired Pneumonia
ACPE #: 0204-0000-21-991-H01-P

  • Develop treatment and monitoring plans for a complex critical care patient with hyperglycemic emergency and community-acquired pneumonia.
  • Select appropriate routes and methods of administration for medications in critically ill patients.
  • Select fluid, electrolyte, and acid/base management and monitoring based on patient-specific factors.
  • Choose agents for acute volume resuscitation.
  • Identify medication safety issues for patients requiring care in the ICU.
  • Explain nutrition support in critically ill patients.

Complex Case: Pneumonia
ACPE #: 0204-0000-21-992-H01-P

  • Develop treatment and monitoring plans for a complex critical care patient with multiple conditions, including pneumonia and acute respiratory distress syndrome (ARDS).
  • Identify drug interactions and adverse drug events common in critical care and methods to document.

Complex Case: Oncologic Emergencies: Febrile Neutropenia, Tumor Lysis Syndrome, and Hypercalcemia of Malignancy
ACPE #: 0204-0000-21-993-H01-P

  • Develop treatment and monitoring plans for a complex critical care patient with febrile neutropenia, tumor lysis syndrome, or hypercalcemia of malignancy.
  • Select fluid, electrolyte and acid/base management and monitoring based on patient-specific factors.
  • Evaluate the impact of critical illness on pre-existing conditions (e.g., cancer).

Complex Case: GI Bleeding and Acute Renal Failure
ACPE #: 0204-0000-21-994-H01-P

  • Develop treatment and monitoring plans for a complex critical care patient with gastrointestinal bleeding, alcohol withdrawal, refeeding syndrome, hepatorenal syndrome, cirrhosis, and acute renal failure with renal replacement therapy.
  • Modify treatment and monitoring plans related to alterations of pharmacodynamics and pharmacokinetics in the critically ill.
  • Select appropriate routes of administration for medications in critically ill patients.
  • Recommend agents for acute volume resuscitation and hemostasis (e.g., blood products, hemostatic agents).

Statistics, Evidence-Based Medicine, and Clinical Trial Design
ACPE #: 0204-0000-21-985-H04-P

  • Determine quality and appropriateness of a study by examining study design, statistical analysis, sources of bias, quality of conclusions, and interpretation of graphs.
  • Determine clinical and statistical significance of a study outcome.
  • Determine whether the study applies to a specified patient population.

Practice Administration and Development Part 1
ACPE #: 0204-0000-21-995-H04-P

  • Develop a plan to monitor and evaluate compliance with, and impact of, policies and guidelines (e.g., institutional, evidence based).
  • Describe the application and integration of evidence-based critical care literature into institutional guidelines and processes.
  • Evaluate regulatory/IRB requirements relative to conducting critical care research.
  • Select quality assurance methods and improvement activities, including needs assessment techniques, aimed at enhancing the safety and effectiveness of medication-use processes in the critical care area.

Practice Administration and Development Part 2
ACPE #: 0204-0000-21-996-H04-P

  • Identify metrics for evaluating the quality of critical care pharmacy services (e.g., lengths of ICU stay, mortality, cost-effectiveness, ROI).
  • Examine the evidence-based literature that supports the value of critical care pharmacy.
  • Summarize the factors that enhance the education and training of critical care pharmacists available in published documents from relevant professional societies (e.g., ASHP, ACCP, SCCM).

The Core Therapeutic Modules for Recertification Package consists of 3 activities (see table below). In each activity, faculty review clinical topics and practice skills using a case-based approach. This package is intended for board certified pharmacists in need of recertification credit; the activities were designed based on the content outline developed by the Board of Pharmacy Specialties (BPS).

Learning Activity

ACPE Number

Contact

Hours

*Assessment Pass Point

Select Topics in Acid-Base Disorders

0204-0000-21-610-H01-P

1.25

76%

Alterations in Pharmacokinetics and Pharmacodynamics in Critical Care

0204-0000-21-611-H01-P

1.00

Select Topics in Toxicology

0204-0000-21-612-H01-P

1.00

Total contact hours   

3.25

 

After participating in these CPE activities, learners should be able to:

Select Topics in Acid-Base Disorders
ACPE #: 0204-0000-21-610-H01-P

For the following specific acid/base disorders - respiratory, metabolic acid base disorders including anion gap/non-anion gap acidosis, renal tubular acidosis, as well as delta gap equation:

  • Interpret laboratory and diagnostic tests.
  • Recommend the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines

Alterations in Pharmacokinetics and Pharmacodynamics in Critical Care
ACPE #: 0204-0000-21-611-H01-P

  • Identify pharmacokinetic and pharmacodynamic (PK/PD) changes that occur in critical illness, and the impact on commonly administered medications in this setting.
  • Apply knowledge of general PK/PD changes in critical illness to the following patient-specific factors that further complicate drug dosing:
    • Burns
    • Obesity
    • Pregnancy
    • Continuous renal replacement therapy (CRRT)
    • Extracorporeal membrane oxygenation (ECMO)
  • Develop a therapeutic strategy to optimize PK/PK for commonly used medications in the intensive care unit.

Select Topics in Toxicology
ACPE #: 0204-0000-21-612-H01-P

For the following specific toxicology topics: acetaminophen, toxic alcohols, calcium channel blockers, beta blockers, opioids, and ecstasy:

  • Interpret laboratory and diagnostic tests
  • Recommend the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines

Faculty bios

REVIEW COURSE

Kevin E. Anger, Pharm.D., BCPS
Pharmacy Supervisor
Brigham and Women's Hospital
Boston, Massachusetts

Angela Bingham, Pharm.D., BCPS, BCNSP, BCCCP, FASPEN, FCCP*
Interim Vice Chair and Associate Professor of Clinical Pharmacy, PGY2 Critical Care Pharmacy Residency Program Director, Residency Programs Coordinator
Philadelphia College of Pharmacy, University of the Sciences
Philadelphia, Pennsylvania
Critical Care Clinical Pharmacy Specialist
Cooper University Hospital
Camden, New Jersey

Brian Dee, Pharm.D., BCCCP, BCNSP, FCCM
Clinical Pharmacy Specialist - Critical Care/Nutrition Support
The University of Texas MD Anderson Cancer Center
Houston, Texas

Mojdeh Heavner
Associate Professor and Vice Chair for Clinical Services
University of Maryland School of Pharmacy
Baltimore, Maryland

Mary M. Hess, Pharm.D., FASHP, FCCM, FCCP, BCCCP*
Associate Dean
Professor, Pharmacy Practice
Jefferson College of Pharmacy
Philadelphia, Pennsylvania

G. Morgan Jones, Pharm.D., BCCCP, FCCM
Clinical Pharmacy Specialist – Neurocritical Care
Methodist University Hospital
Assistant Professor of Neurology, Neurosurgery, and Clinical Pharmacy and Translational Sciences
University of Tennessee Health Sciences Center
Memphis, Tennessee

Patricia Kienle, M.P.A., BCSCP, FASHP
Director, Accreditation and Medication Safety
Cardinal Health
Wilkes-Barre, Pennsylvania

Daniel R. Malcom, Pharm.D., BCPS, BCCCP
Associate Professor and Chair, Department of Pharmacy Practice
Sullivan University College of Pharmacy and Health Sciences
Louisville, Kentucky

John Marshall, Pharm.D., BCPS, BCCCP, FCCM
Director, Clinical Pharmacy Programs
Massachusetts General Hospital
Boston, Massachusetts

Krystal Moorman, Pharm.D., BCPS
Director Experiential Education and Assistant Clinical Professor
University of Utah College of Pharmacy
Salt Lake City, Utah

Jill Starykowicz, Pharm.D., BCCCP
Clinical Pharmacy Specialist, Cardiology/Medical Intensive Care
AdvocateLutheran General Hospital
Park Ridge, Illinois

Rachel Swope, Pharm.D., BCCCP
Clinical Pharmacy Manager
Norton Healthcare
Louisville, Kentucky

Paul Szumita, Pharm.D., BCCCP, BCPS, FASHP, FCCM*
Director of Clinical Pharmacy
Brigham & Women's Hospital
Boston, Massachusetts

Heather Torbic, Pharm.D., BCPS, BCCCP
Medical ICU Clinical Pharmacy Specialist
Cleveland Clinic
Cleveland, Ohio

*Content Matter Experts

Holly L. Byrnes, Pharm D., BCPS
Susan R. Dombrowski, M.S., R.Ph.
Jill A. Sellers, B.S.Pharm., Pharm.D..

REVIEW COURSE

Shannon Allcron, Pharm.D., BCCCP, BCPS
Esraa Altawil, M.Sc., BCPS, BCNSP, BCCCP
Rachel Anderson, Pharm.D., BCPS, BCCCP
John Austin, Pharm.D., BCPS, BCCCP
Allison Barnum, Pharm.D., BCCCP
Brian Baum, Pharm.D., M.S., M.B.A., BCPS, BCCCP
Neela Bhajandas, Pharm.D., BCPS, BCCCP
Quintin Broussard, Pharm.D., BCPS, BCCCP, BCNSP
Judah Brown, Pharm.D., BCCCP
Jeff Bruno, Pharm.D., BCPS, BCNSP, BCCCP
Jeffrey Bruno, Pharm.D., BCPS, BCNSP, BCCCP
Eugene Bush, RPh, PhD, BCPS, BCCCP
Elizabeth Canterbury, Pharm.D., BCCCP
Jennifer Catlin, Pharm.D., BCPS, BCCCP
Genevieve Cheung, Pharm.D, BCCCP
Ryan Cook, Pharm.D., BCPS, BCCCP
Courtney Cox, Pharm.D., BCCCP
Robert Crawley, Pharm.D., BCPS, BCCCP
Robert Dannemiller, Pharm.D., BCPS, BCCCP
Rosanna Dastoori, Pharm.D., BCPS, BCCCP
Aubrey Defayette, Pharm.D., BCCCP
Calvin Diep, Pharm.D.
Roxana Dumitru, Pharm.D., BCPS, BCCCP
Karly Erickson, Pharm.D., BCPS, BCCCP
Adonia Eskandari, Pharm.D., BCCCP
Lane Farrell, Pharm.D., BCCCP
Megan Feeney, Pharm.D., BCCCP
Nadia Ferguson, Pharm.D., BCPS, BCCP
April Finnigan, Pharm.D., BCCCP
Stefanie Forman, Pharm.D., BCPS, BCCCP
Mercedes Fraga, Pharm.D., BCPS, BCCCP, BCIDP
Nicholas Franz, Pharm.D., BCCCP
Christen Freeman, Pharm.D., M.B.A., BCCCP, CNSC
Lauren Fruhling, Pharm.D. BCCCP
Dania Ghaziri, Pharm.D, BCPS, BCCCP
Jonathan Gray, Pharm.D.,BCCCP
Gloria Gutierrez, Pharm.D. BCCCP
Julie Haase, Pharm.D., BCPS, BCCCP
Brianne Hansen, Pharm.D., BCPS, BCCCP
Coleen Hart, Pharm.D, BCPS, BCCCP
Ashley Hawthorne, Pharm.D., BCCCP
Lisa Hayes, Pharm.D., BCCCP
Miranda Howland, Pharm.D., BCCCP
Sara J. Hyland, Pharm.D., BCCCP
John Johnson, B.Pharm, BCPS, BCNSP, BCCCP
William Johnson, Pharm.D., BCCCP
Sarah Jung, Pharm.D., M.S., BCCCP
Nirali Kalaria, Pharm.D., BCCCP
Kevin Kaucher, Pharm.D., BCCCP
Chelsea Krueger, Pharm.D., BCCCP
Kaitlin Landolf, Pharm.D., BCCCP
Tracey Le, Pharm.D., BCCCP
Jacky Lee, Pharm.D., BCPS, BCCCP
David Li, Pharm.D., BCCCP, CNSC
Shiao Hui Lim , MPharm, BCCCP
Man Soi Lo, BCCCP
Melanie Madorsky, Pharm.D., BCPS, BCCP, BCCCP
BrookeAnne Magrum, Pharm.D., BCCCP
Therese Makhoul, Pharm.D., BCCCP
Lindsay McCann, Pharm.D., BCCCP
Wayne McDermott, Pharm.D.
Michael McQuade, Pharm.D., BCCCP, BCPS
Minoo Moradi, Pharm.D.,BCCCP
Matthew Morrisette, Pharm.D., BCCCP
Oussayma Moukhachen, Pharm.D., BCPS, BCCCP
Chris Oswald, Pharm.D., BCPS, BCCCP
Daniel Padgett, Pharm.D., BCPS, BCCCP
Christine Parker, Pharm.D., BCPS, BCCCP
Stacy Pasciolla, Pharm.D., BCCCP
Jaimini Patel, Pharm.D., BCCCP
Jina Patel, Pharm.D., BCCCP
Nishika Patel, Pharm.D., BCPS, BCCCP
Aaron Peck, Pharm.D., BCCCP
Felix Pham, Pharm.D.
Kelvin Pham, Pharm.D.
Abbey Pitzenberger, Pharm.D., BCCCP, BCPS
Hal Piwonka, Pharm.D., BCCCP
Alyssa Polotti, Pharm.D., BCCCP
Denise Pratt, Pharm.D., BCCCP
Kaitlin Pruskowski, Pharm.D., BCPS, BCCCP
Mike Reed, B.S.Pharm., BCPS, BCOP, BCCCP
David Reynolds, Pharm.D., BCPS, BCCCP
Alyssa Robertson, Pharm.D., BCPS, BCCCP
Tara Ruder, Pharm.D. BCCCP
Klayton Ryman, Pharm.D., BCCCP
Alicia Sacco, Pharm.D., BCCCP
Brandon Scholes, Pharm.D., BCCCP
Stephanee Schrader, Pharm.D., BCCCP
Ashley Schuler, Pharm.D., BCCCP
Tram Simmons, Pharm.D., BCPS, BCCCP
Ravipal Singh, Pharm.D., BCCCP
Luke Smedley, Pharm.D., BCCCP
Rebecca Smith, Pharm.D., BCCCP
Stephanie Smith, Pharm.D., BCCCP
Zachary Smith, Pharm.D., BCPS, BCCCP
Dilraj Sohal, Pharm.D.
Terri Tieman, Pharm.D., BCPS, BCCCP
Adrienne Udelhoven, Pharm.D., BCPS, BCCCP
Johnathan Voss, Pharm.D., BCCCP, BCNSP
Krista Wahby, Pharm.D., BCCCP
Chelsea Wampole, Pharm.D., BCCCP
Melanie Yerondopoulos, Pharm.D., BCCCP

CORE THERAPEUTIC MODULES

Shannon Allcron, Pharm.D., BCCCP, BCPS
Rachel Anderson, Pharm.D., BCPS, BCCCP
John Austin, Pharm.D., BCPS, BCCCP
Neela Bhajandas, Pharm.D., BCPS, BCCCP
Jennifer Catlin, Pharm.D., BCPS, BCCCP
Genevieve Cheung, Pharm.D., BCCCP
Ryan Cook, Pharm.D., BCPS, BCCCP
Rosanna dastoori, Pharm.D., BCPS, BCCCP
Adonia Eskandari, Pharm.D., BCCCP
Lane Farrell, Pharm.D., BCCCP
Nadia Ferguson-Myrthil, Pharm.D., BCCCP
April Finnigan, Pharm.D., BCCCP
Stefanie Forman, Pharm.D., BCPS, BCCCP
Jonathan Gray, Pharm.D., BCCCP
Coleen Hart, Pharm.D., BCPS, BCCCP
Ashley Hawthorne, Pharm.D., BCCCP
Lisa Hayes, Pharm.D. BCCCP
John Johnson, B.Pharm, BCPS, BCNSP, BCCCP
William Johnson, Pharm.D., BCCCP
Nirali Kalaria, Pharm.D., BCCCP
Kevin Kaucher, Pharm.D., BCCCP
BrookeAnne Magrum, Pharm.D.
Lindsay McCann, Pharm.D., BCCCP
Chris Oswald, Pharm.D., BCPS, BCCCP
Daniel Padgett, Pharm.D., BCPS, BCCCP
Christine Parker, Pharm.D., BCPS, BCCCP
Stacy Pasciolla, Pharm.D., BCCCP
Jina Patel, Pharm.D., BCCCP
Nishika Patel, Pharm.D., BCPS, BCCCP
Felix Pham, Pharm.D.
Alyssa Polotti, Pharm.D., BCCCP
Kaitlin Pruskowski, Pharm.D., BCPS, BCCCP
Alyssa Robertson, Pharm.D., BCPS, BCCCP
Tara Ruder, Pharm.D. BCCCP
Brandon Scholes, Pharm.D., BCCCP
Stephanee Schrader, Pharm.D, BCCCP
Luke Smedley, Pharm.D., BCCCP
Stephanie Smith, Pharm.D., BCCCP
Krista Wahby, Pharm.D., BCCCP
Melanie Yerondopoulos, Pharm.D., BCCCP

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

  • Brian Dee: Spouse employed by Pfizer
  • Patricia Kienle: Cardinal Health (employee), CriticalPoint LLC (instructor), USP (volunteer, ASHP author)

All other planners, presenters, and reviewers of this session report no financial relationships relevant to this activity.

Methods and CE Requirements

Activities can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

Development

These activities were developed by ASHP.

To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for Board Certification Examinations.